Evidence map›Paper›PMID 32024968›Full record

ArticleOncogene2020

mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca

Saranya NavaneethaKrishnan, Jesusa L Rosales, Ki-Young Lee

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Requirement for ER-mitochondria CaFrontiers in cell and developmental biology · 2023
    Article
  18. Review
  19. Cdk5 regulates IP3R1-mediated CaCellular and molecular life sciences : CMLS · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Saranya NavaneethaKrishnanDepartments of Cell Biology and Anatomy, Arnie Charbonneau Cancer Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Jesusa L RosalesDepartments of Cell Biology and Anatomy, Arnie Charbonneau Cancer Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Ki-Young LeeDepartments of Cell Biology and Anatomy, Arnie Charbonneau Cancer Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. kylee@ucalgary.ca.ORCID http://orcid.org/0000-0002-5387-2692
University of Calgary · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) MOP-123400
6 · The paper itself

Abstract

We previously demonstrated that loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death by inducing mitochondrial permeability transition pore (mPTP) opening (Oncogene 37, 1788-1804). However, the molecular mechanism by which Cdk5 loss causes mPTP opening remains to be investigated. Using primary mouse embryonic fibroblasts (MEFs) isolated from Cdk5

Indexed as

AnimalsCalciumCations, DivalentCells, CulturedCyclin-Dependent Kinase 5Embryo, MammalianEndoplasmic ReticulumFemaleMice, KnockoutMicroscopy, Electron, TransmissionMitochondriaMitochondrial Permeability Transition PorePrimary Cell CultureReactive Oxygen SpeciesCalciumCations, DivalentCdk5 protein, mouseCyclin-Dependent Kinase 5Mitochondrial Permeability Transition PoreReactive Oxygen Species

Identifiers

PMID32024968
PMCPMC7098883
OpenAlexW3004761768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.